Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Partha Ghosh is active.

Publication


Featured researches published by Partha Ghosh.


Organic Letters | 2009

Asymmetric total synthesis of alkaloids 223A and 6-epi-223A.

Partha Ghosh; Weston R. Judd; Timothy Ribelin; Jeffrey Aubé

Concise and asymmetric total synthesis of the title compounds are described. The key ring system was constructed using an intramolecular Schmidt reaction on a norbornenone derivative, which was subsequently subjected to ring-opening metathesis followed by reduction. An unusual isomerization of the C-6 ethyl group afforded the desired stereochemistry of the natural product. The synthesis is readily adaptable to analogue production.


Journal of Biomolecular Screening | 2014

Identification of potent and selective inhibitors of the plasmodium falciparum M18 aspartyl aminopeptidase (PfM18AAP) of human malaria via high-throughput screening

Timothy P. Spicer; Virneliz Fernandez-Vega; Peter Chase; Louis Scampavia; Joyce To; John P. Dalton; Fabio L. da Silva; Tina S. Skinner-Adams; Donald L. Gardiner; Katharine R. Trenholme; Christopher L. Brown; Partha Ghosh; Patrick Porubsky; Jenna L. Wang; David A Whipple; Frank J. Schoenen; Peter Hodder

The target of this study, the PfM18 aspartyl aminopeptidase (PfM18AAP), is the only AAP present in the genome of the malaria parasite Plasmodium falciparum. PfM18AAP is a metallo-exopeptidase that exclusively cleaves N-terminal acidic amino acids glutamate and aspartate. It is expressed in parasite cytoplasm and may function in concert with other aminopeptidases in protein degradation, of, for example, hemoglobin. Previous antisense knockdown experiments identified a lethal phenotype associated with PfM18AAP, suggesting that it is a valid target for new antimalaria therapies. To identify inhibitors of PfM18AAP function, a fluorescence enzymatic assay was developed using recombinant PfM18AAP enzyme and a fluorogenic peptide substrate (H-Glu-NHMec). This was screened against the Molecular Libraries Probe Production Centers Network collection of ~292,000 compounds (the Molecular Libraries Small Molecule Repository). A cathepsin L1 (CTSL1) enzyme-based assay was developed and used as a counterscreen to identify compounds with nonspecific activity. Enzymology and phenotypic assays were used to determine mechanism of action and efficacy of selective and potent compounds identified from high-throughput screening. Two structurally related compounds, CID 6852389 and CID 23724194, yielded micromolar potency and were inactive in CTSL1 titration experiments (IC50 >59.6 µM). As measured by the Ki assay, both compounds demonstrated micromolar noncompetitive inhibition in the PfM18AAP enzyme assay. Both CID 6852389 and CID 23724194 demonstrated potency in malaria growth assays (IC50 4 µM and 1.3 µM, respectively).


Journal of Organic Chemistry | 2011

Resolution of Carboxylic Acids Using Copper (I)-Promoted Removal of Propargylic Esters Under Neutral Conditions

Partha Ghosh; Jeffrey Aubé

A method for the optical resolution of carboxylic acids is described. Condensation of racemic carboxylic acids with chiral terminal propargyl alcohols gave separable diastereomeric esters. Chromatographic separation followed by heating the individual diastereomers in methanol with catalytic copper(I) halide regenerated the carboxylic acids in good yields and in enantiomeric ratios of ≥94%. This method is particularly useful for the resolution of carboxylic acids that are incompatible with conventional ester hydrolysis.


Journal of Organic Chemistry | 2015

Domino Acylation/Diels–Alder Synthesis of N-Alkyl-octahydroisoquinolin-1-one-8-carboxylic Acids under Low-Solvent Conditions

Stephen R. Slauson; Ryan P. Pemberton; Partha Ghosh; Dean J. Tantillo; Jeffrey Aubé

The development of the domino reaction between an aminoethyl-substituted diene and maleic anhydride to afford an N-substituted octahydroisoquinolin-1-one is described. A typical procedure involves the treatment of a 1-aminoethyl-substituted butadiene with maleic anhydride at 0 °C to room temperature for 20 min under low-solvent conditions, which affords a series of isoquinolinone carboxylic acids in moderate to excellent yields. NMR monitoring suggested that the reaction proceeded via an initial acylation step followed by an intramolecular Diels-Alder reaction. For the latter step, a significant rate difference was observed depending on whether the amino group was substituted by a phenyl or an alkyl (usually benzyl) substituent, with the former noted by NMR to be substantially slower. The Diels-Alder step was studied by density functional theory (DFT) methods, leading to the conclusion that the degree of preorganization in the starting acylated intermediate had the largest effect on the reaction barriers. In addition, the effect of electronics on the aromatic ring in N-phenyl substrates was studied computationally and experimentally. Overall, this protocol proved considerably more amenable to scale up compared to earlier methods by eliminating the requirement of microwave batch chemistry for this reaction as well as significantly reducing the quantity of solvent.


ACS Chemical Neuroscience | 2012

Discovery of small molecule kappa opioid receptor agonist and antagonist chemotypes through a HTS and Hit refinement strategy

Kevin J. Frankowski; Michael Hedrick; Palak Gosalia; Kelin Li; Shenghua Shi; David A Whipple; Partha Ghosh; Thomas E. Prisinzano; Frank J. Schoenen; Ying Su; Stefan Vasile; Eduard Sergienko; Wilson Gray; Santosh Hariharan; Loribelle Milan; Susanne Heynen-Genel; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; John M. Streicher; Marc G. Caron; Larry S. Barak; Laura M. Bohn; Thomas Dy Chung; Jeffrey Aubé


ACS Medicinal Chemistry Letters | 2010

N-Alkyl-octahydroisoquinolin-1-one-8-carboxamides: Selective and Nonbasic κ-Opioid Receptor Ligands

Kevin J. Frankowski; Partha Ghosh; Vincent Setola; Thuy B. Tran; Bryan L. Roth; Jeffrey Aubé


Archive | 2014

Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase

Frank J. Schoenen; Warren S. Weiner; Pierre Baillargeon; Christopher L. Brown; Peter Chase; Jill Ferguson; Virneliz Fernandez-Vega; Partha Ghosh; Peter Hodder; Jeffrey P. Krise; Daljit S. Matharu; Benjamin Neuenswander; Patrick Porubsky; Steven A. Rogers; Tina S. Skinner-Adams; Melinda Sosa; Timothy P. Spicer; Joyce To; Nichole A. Tower; Katharine R. Trenholme; Jenna Wang; David A Whipple; Jeffrey Aubé; Hugh Rosen; E. Lucile White; John P. Dalton; Donald L. Gardiner


Archive | 2010

Selective KOP Receptor Agonists: Probe 1 & Probe 2

Michael Hedrick; Palak Gosalia; Kevin J. Frankowski; Shenghua Shi; Thomas E. Prisinzano; Frank J. Schoenen; Jeffrey Aubé; Ying Su; S Vasile; Eduard Sergienko; Wilson Gray; Santosh Hariharan; Partha Ghosh; Loribelle Milan; Susanne Heynen-Genel; Thomas Dy Chung; Shakeela Dad; Marc G. Caron; Laura M. Bohn; Larry S. Barak


Archive | 2010

Table 3, SAR Analysis for Selective κ–opioid receptor agonist for the Bisamide Scaffold

Michael Hedrick; Palak Gosalia; Kevin J. Frankowski; Shenghua Shi; Thomas E Prisinzano; Frank Schoenen; Jeffrey Aubé; Ying Su; S Vasile; Eduard Sergienko; Wilson Gray; Santosh Hariharan; Partha Ghosh; Loribelle Milan; Susanne Heynen-Genel; Thomas Dy Chung; Shakeela Dad; Marc Caron; Laura M Bohn; Lawrence S Barak


Archive | 2010

Table 7, Summary of in vitro ADME/T Properties of Kappa Opioid Agonist probe(s)

Michael Hedrick; Palak Gosalia; Kevin J. Frankowski; Shenghua Shi; Thomas E Prisinzano; Frank Schoenen; Jeffrey Aubé; Ying Su; S Vasile; Eduard Sergienko; Wilson Gray; Santosh Hariharan; Partha Ghosh; Loribelle Milan; Susanne Heynen-Genel; Thomas Dy Chung; Shakeela Dad; Marc Caron; Laura M Bohn; Lawrence S Barak

Collaboration


Dive into the Partha Ghosh's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frank Schoenen

University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Laura M Bohn

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marc Caron

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeffrey Aubé

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge